FORMULATION FOR ORAL USE COMPRISING OZONATED OIL IN THE PREVENTION AND/OR TREATMENT OF SYSTEMIC TISSUE DISEASES CAUSED BY MONOCYTE INFLAMMATION

摘要

The present invention relates to the use of a formulation for oral use comprising ozonated oil in the prevention and/or treatment by oral administration of systemic tissue diseases caused by monocyte inflammation, more in particular skin and/or mucous membrane lesions caused by the exposure to ionizing radiations and/or chemotherapeutic treatment.